Consistently, LINC00662 has been shown to be overexpressed in many different tumors, including lung cancer, breast cancer, cervical cancer, prostate cancer, chordoma, glioma, gastric cancer, and hepatocellular carcinoma. This evidence concerns the gene LINC00662 and glioma.